Latest Insider Transactions at Brp Group, Inc. (BRP)
This section provides a real-time view of insider transactions for Brp Group, Inc. (BRP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BRP Group, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BRP Group, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2025
|
Lowry Baldwin Director |
SELL
Open market or private sale
|
Indirect |
90,099
-75.34%
|
$3,513,861
$39.67 P/Share
|
|
Mar 03
2025
|
Baldwin Insurance Group Holdings, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
200,000
-0.52%
|
-
|
|
Mar 03
2025
|
Lowry Baldwin Director |
SELL
Open market or private sale
|
Indirect |
34,901
-15.08%
|
$1,396,040
$40.17 P/Share
|
|
Mar 03
2025
|
Lowry Baldwin Director |
BUY
Conversion of derivative security
|
Indirect |
125,000
+50.0%
|
-
|
|
Mar 03
2025
|
Lowry Baldwin Director |
SELL
Conversion of derivative security
|
Indirect |
125,000
-100.0%
|
-
|
|
Mar 03
2025
|
Lowry Baldwin Director |
BUY
Other acquisition or disposition
|
Indirect |
125,000
+50.0%
|
-
|
|
Mar 03
2025
|
Lowry Baldwin Director |
SELL
Other acquisition or disposition
|
Indirect |
200,000
-0.52%
|
-
|
|
Feb 28
2025
|
James Morgan Roche Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,637
-7.7%
|
$477,117
$41.14 P/Share
|
|
Feb 28
2025
|
James Morgan Roche Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,759
+15.04%
|
-
|
|
Feb 28
2025
|
Corbyn N. Galloway Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,086
+8.04%
|
-
|
|
Feb 28
2025
|
Corbyn N. Galloway Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,752
-5.54%
|
$112,832
$41.14 P/Share
|
|
Feb 28
2025
|
Seth Bala Cohen General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,437
-19.2%
|
$181,917
$41.14 P/Share
|
|
Feb 28
2025
|
Seth Bala Cohen General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
14,302
+38.22%
|
-
|
|
Feb 28
2025
|
Trevor Baldwin Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,363
-12.51%
|
$875,883
$41.14 P/Share
|
|
Feb 28
2025
|
Trevor Baldwin Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
54,290
+24.12%
|
-
|
|
Feb 28
2025
|
Bradford Hale Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,667
-7.29%
|
$437,347
$41.14 P/Share
|
|
Feb 28
2025
|
Bradford Hale Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,110
+15.63%
|
-
|
|
Feb 28
2025
|
Daniel Galbraith Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,825
-19.74%
|
$443,825
$41.14 P/Share
|
|
Feb 28
2025
|
Daniel Galbraith Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,510
+33.41%
|
-
|
|
Feb 27
2025
|
Seth Bala Cohen General Counsel |
SELL
Open market or private sale
|
Direct |
12,293
-58.24%
|
$504,013
$41.54 P/Share
|
|
Feb 19
2025
|
Trevor Baldwin Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,741
-18.67%
|
$1,069,640
$40.85 P/Share
|
|
Feb 19
2025
|
Trevor Baldwin Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
76,937
+34.95%
|
-
|
|
Feb 19
2025
|
James Morgan Roche Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,397
-8.39%
|
$455,880
$40.85 P/Share
|
|
Feb 19
2025
|
James Morgan Roche Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,927
+16.55%
|
-
|
|
Feb 19
2025
|
Seth Bala Cohen General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,192
-16.57%
|
$167,680
$40.85 P/Share
|
|
Feb 19
2025
|
Seth Bala Cohen General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
16,485
+39.45%
|
-
|
|
Feb 19
2025
|
Daniel Galbraith Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,928
-30.38%
|
$477,120
$40.85 P/Share
|
|
Feb 19
2025
|
Daniel Galbraith Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,972
+45.65%
|
-
|
|
Feb 19
2025
|
Corbyn N. Galloway Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,444
-5.54%
|
$97,760
$40.85 P/Share
|
|
Feb 19
2025
|
Corbyn N. Galloway Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,593
+13.0%
|
-
|
|
Feb 19
2025
|
Bradford Hale Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,929
-9.1%
|
$477,160
$40.85 P/Share
|
|
Feb 19
2025
|
Bradford Hale Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,972
+20.1%
|
-
|
|
Jan 01
2025
|
Sunita Parasuraman Director |
BUY
Grant, award, or other acquisition
|
Direct |
614
+6.5%
|
-
|
|
Jan 01
2025
|
Barbara Ruth Matas Director |
BUY
Grant, award, or other acquisition
|
Direct |
614
+4.2%
|
-
|
|
Jan 01
2025
|
Joseph John Kadow Director |
BUY
Grant, award, or other acquisition
|
Direct |
614
+4.2%
|
-
|
|
Jan 01
2025
|
Jay A Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
614
+4.51%
|
-
|
|
Jan 01
2025
|
Chris Thomas Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
614
+0.72%
|
-
|
|
Jan 01
2025
|
Ellyn Shook Director |
BUY
Grant, award, or other acquisition
|
Direct |
614
+6.5%
|
-
|
|
Jan 01
2025
|
Sathish Muthukrishnan Director |
BUY
Grant, award, or other acquisition
|
Direct |
614
+11.68%
|
-
|
|
Jan 01
2025
|
Myron K Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
614
+6.5%
|
-
|
|
Dec 11
2024
|
Elizabeth Krystyn |
SELL
Open market or private sale
|
Indirect |
88,306
-100.0%
|
$3,797,158
$43.05 P/Share
|
|
Dec 10
2024
|
Elizabeth Krystyn |
SELL
Open market or private sale
|
Indirect |
144,264
-38.35%
|
$6,203,352
$43.89 P/Share
|
|
Dec 09
2024
|
Elizabeth Krystyn |
SELL
Open market or private sale
|
Indirect |
191,307
-16.06%
|
$8,800,122
$46.0 P/Share
|
|
Dec 09
2024
|
Elizabeth Krystyn |
BUY
Conversion of derivative security
|
Indirect |
423,877
+50.0%
|
-
|
|
Dec 09
2024
|
Elizabeth Krystyn |
SELL
Conversion of derivative security
|
Indirect |
423,877
-22.73%
|
-
|
|
Oct 04
2024
|
Laura Sherman |
BUY
Bona fide gift
|
Indirect |
3,036
+0.14%
|
-
|
|
Oct 04
2024
|
Laura Sherman |
SELL
Bona fide gift
|
Direct |
3,036
-100.0%
|
-
|
|
Oct 04
2024
|
Elizabeth Krystyn |
BUY
Bona fide gift
|
Indirect |
12,124
+0.65%
|
-
|
|
Oct 04
2024
|
Elizabeth Krystyn |
SELL
Bona fide gift
|
Direct |
12,124
-100.0%
|
-
|
|
Oct 03
2024
|
Laura Sherman |
SELL
Bona fide gift
|
Indirect |
60,992
-52.49%
|
-
|